16 CFR 1028.113 - Suspension or termination of IRB approval of research.

Beta! The text on the eCFR tab represents the unofficial eCFR text at ecfr.gov.
§ 1028.113 Suspension or termination of IRB approval of research.

An IRB shall have authority to suspend or terminate approval of research that is not being conducted in accordance with the IRB's requirements or that has been associated with unexpected serious harm to subjects. Any suspension or termination of approval shall include a statement of the reasons for the IRB's action and shall be reported promptly to the investigator, appropriate institutional officials, and the department or agency head.

(Approved by the Office of Management and Budget under Control Number 0990-0260)
[56 FR 28012, 28019, June 18, 1991, as amended at 70 FR 36328, June 23, 2005]

This is a list of United States Code sections, Statutes at Large, Public Laws, and Presidential Documents, which provide rulemaking authority for this CFR Part.

This list is taken from the Parallel Table of Authorities and Rules provided by GPO [Government Printing Office].

It is not guaranteed to be accurate or up-to-date, though we do refresh the database weekly. More limitations on accuracy are described at the GPO site.


United States Code
U.S. Code: Title 42 - THE PUBLIC HEALTH AND WELFARE

Title 16 published on 2015-01-01

The following are ALL rules, proposed rules, and notices (chronologically) published in the Federal Register relating to 16 CFR Part 1028 after this date.

  • 2015-12-01; vol. 80 # 230 - Tuesday, December 1, 2015
    1. 80 FR 75020 - Protection of Human Subjects
      GPO FDSys XML | Text
      CONSUMER PRODUCT SAFETY COMMISSION, 16 CFR Part 1028
      Notice of proposed rulemaking; extension of comment period.
      The comment period for the CPSC's NPR published on September 24, 2015 (80 FR 57549), is extended by 30 days and thus will end on January 6, 2016.